Skip to content

Iceland vs Sweden Tech Ecosystem

How the two compare on size, sectors, cities and company age.

Metric Iceland Sweden
Company count 19 35
Top industries BioTech, FinTech, HealthTech FinTech, AI, ClimateTech
Top cities Reykjavik, Isafjordur, Keflavik Stockholm, Gothenburg, Helsingborg
Avg founded year 2016 2017
Employee range 1-1000 1-10000

Top Iceland companies

Top Sweden companies

Iceland vs Sweden

Iceland vs Sweden — One Half-Billion-Dollar Anchor vs an Entire IPO Pipeline

The strongest population-versus-output asymmetry in the directory. Sweden brings hundreds of companies and a public-market machine. Iceland answers with Alvotech, the Kerecis exit as precedent, and disproportionately cheap clean compute.

Read the full analysis

Sweden has roughly 27 times Iceland’s population and produces somewhere closer to 50 times its absolute startup output. The directory split is the largest in this comparison set.

Sweden’s strength is the depth of the pipeline. Stockholm comes closer to a tier-one venture city than anywhere else in Europe, with Klarna on the NYSE at $19B, Lovable at a $6.6B private valuation against $400M ARR, Voi exploring an IPO off real profitability, and Spotify anchoring the public-market reference set. The bench behind those flagships runs hundreds of companies deep across SaaS, fintech, climatetech, gaming, and consumer.

Iceland’s strength is precision. Alvotech reported $593M revenue in 2025, larger than every Nordic healthcare operator in the directory combined. Kerecis sold to Coloplast for $1.3B. Sidekick Health covers digital therapeutics. The country has produced exactly one half-billion-dollar revenue operator and a small handful of consequential exits, but per-capita output is high all the same. Add geothermal-powered HPC capacity for AI workloads, which makes Reykjavik unusually competitive on cost-of-compute terms and rarely gets counted in the startup numbers.

Stage settles the decision. A Series-B-and-up company that needs growth capital and IPO mechanics has no reason to look past Stockholm. A small biotech, or an AI or deeptech team that wants the lowest possible cost-of-compute clean energy, has a real argument for Reykjavik (and the directory still has room to add more of those).

The one risk worth naming for Iceland is single-site exposure. Alvotech’s 2025 four-Complete-Response-Letter cascade from a single FDA inspection showed how hard a single regulatory event can rattle a one-flagship economy. Sweden’s diversification is the boring, durable advantage.

The Iceland and Sweden directories show the rest of the split.